Diabetes type 1 vaccine - BioDiscovery

Drug Profile

Diabetes type 1 vaccine - BioDiscovery

Alternative Names: Q-Vax

Latest Information Update: 30 Mar 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator BioDiscovery; John Curtin School of Medical Research
  • Class Antihyperglycaemics; Diabetes mellitus vaccines; Vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Type 1 diabetes mellitus

Most Recent Events

  • 22 Aug 2002 This vaccine is still in active development for use in type 1 diabetes
  • 03 Dec 1998 New profile
  • 03 Dec 1998 Phase-II clinical trials for Type-1 diabetes mellitus in Australia (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top